华润医药(03320)附属华润医药商业完成发行30亿元中期票据

Core Viewpoint - China Resources Pharmaceutical (03320) has successfully issued the first phase of its 2025 medium-term notes, raising a total of RMB 3 billion with a maturity of three years and an annual interest rate of 2.19 [1] Group 1 - The first phase of the 2025 medium-term notes was completed on December 15, 2025 [1] - The funds raised from this issuance will be used to repay interest-bearing debts of China Resources Pharmaceutical Commercial or its subsidiaries [1]